Skip to main content
Sajeth Dinakaran on Muck Rack

Sajeth Dinakaran

As seen in: BioRxiv, Lexology, Mondaq
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sajeth

Contact Sajeth, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia

|
By Sajeth Dinakaran, Haitian Zhao, Yuefeng Tang, Zhimin Wang
| BioRxiv
Abstract Increased endothelial cell (EC) proliferation is a hallmark of arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia (HHT). The underlying mechanism and disease relevance of this abnormal cell proliferative state of the ECs remain unknown. Here, we report the identification of a CDK6-driven mechanism of cell cycle progression deregulation directly involved in EC proliferation and HHT vascular pathology.
Open in Who Shared Issue with article?

Spotlight On Upcoming Oral Arguments – September 2023 - Patent - United States

|
By Jason Zhang, Esther Lim, Sajeth Dinakaran
| Mondaq
The following arguments will be available to the public live, both in-person and through online audio streaming. Access information will be available by 9 AM ET each day of argument at: https://cafc.uscourts.gov/home/oral-argument/listen-to-oral-arguments/.
Open in Who Shared Issue with article?

Spotlight on Upcoming Oral Arguments - September 2023

|
By Sajeth Dinakaran, Jason Zhang, Esther Lim
| Lexology Verified
The following arguments will be available to the public live, both in-person and through online audio streaming. Access information will be available by 9 AM ET each day of argument at: https://cafc.uscourts.gov/home/oral-argument/listen-to-oral-arguments/. Tuesday, September 5, 2023 Purdue Pharma L.P. v.
Open in Who Shared Issue with article?
See all 3 articles